Navigation Links
'Disprin Plus' is now 'Disprin Paracetamol'

Reckitt Benckiser has deferred the launch of 'Disprin CV' (cardiovascular) following the confusion over the name of its new painkiller 'Disprin Plus', the company's Regional Director , Mr. Pranab Barua said. The company also announced a change in the brand-name 'Disprin Plus' to 'Disprin Paracetamol'. Subsequent to the launch of Disprin Plus, there were reports citing instances of concern from doctors and consumers regarding the use of the suffix 'Plus' along with the brand-name, Mr. Barua said.

"This matter was also taken up by the drug aythorities and the company was advised to address this concern.// Taking cognisance of the concern of consumers and the drug authorities, the company decided to change the suffix from 'Plus' to 'Paracetamol', thereby making clear the brand's ingredient ," he said.

Mr. Barua said that the company, which had an inventory of 15 - 20 million tablets worth about Rs 1 crore, will suffer loss of sale for a month during the transition period to the tune of Rs 1.5 - 2 crore. Disprin 'Paracetamol' will be in the market by mid-December , he said. The company has also decided not to give any brand push to Disprin Cold and Flu for similar reasons, Mr. Baura said.

Paracetamol-based Disprin 'Plus' was launched by Reckitt Benckiser (India) in August this year to replace Disprin (350 mg aspirin) in the pain relief segment. Mr. Barua said Disprin CV (100 mg aspirin) will not be launched till the new brand 'Disprin Paracetamol' is completely established.


Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. New spray gel heals surgical wounds
Post Your Comments:

(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: